[SLN] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
15-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -93.76%
YoY- -45.89%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 2,798 9,104 11,374 4,765 3,371 3,643 5,722 -37.90%
PBT -10,661 -12,010 -12,673 -15,050 -9,326 -13,420 -9,572 7.44%
Tax -2,411 -1,609 -2,469 -1,287 -2,223 -1,481 -1,888 17.68%
NP -8,250 -10,401 -10,204 -13,763 -7,103 -11,939 -7,684 4.84%
Tax Rate - - - - - - - -
Total Cost 11,048 19,505 21,578 18,528 10,474 15,582 13,406 -12.08%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -294.85 -114.25 -89.71 -288.84 -210.71 -327.72 -134.29 68.84%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.22 -0.29 -0.28 -0.43 -0.22 -0.40 -0.26 -10.53%
EPS Diluted -0.22 -0.29 -0.28 -0.43 -0.22 -0.40 -0.26 -10.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.